Also found in: Medical.


n. inmunoquimioterapia, proceso combinado de inmunoterapia y quimioterapia aplicado en el tratamiento de ciertos tumores malignos.
References in periodicals archive ?
Dose-escalation study evaluating investigational medicine venetoclax in combination with an immunochemotherapy regimen, bendamustine and rituximab, in patients with NHL
Induction immunochemotherapy was followed by obinutuzumab maintenance therapy.
They describe strategies of passive and active immunotherapy, improving immunotherapeutic responses using combinations of agents for immunochemotherapy, and targeting strategies to defeat immune suppression.
MatBA[R]-DLBCL assesses the presence of single biomarkers as well as genome complexity as measures of overall survival following front-line immunochemotherapy
Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.
Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer.
Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil.
HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK.
To date, the only treatment bearing curative potential is allogeneic stem cell transplantation; in contrast to conventional immunochemotherapy, it can provide long-term disease control, even in patients with del Up or other unfavorable biological and clinical risk factors.
Supportive treatments, IVIG and sometimes immunochemotherapy are the treatment options in IAHS (1,2).
Combined Immunochemotherapy with Rituximab Improves Overall Survival in Patients with Follicular and Mantle Cell Lymphoma: Updated Meta-Analysis Results.